tim akhurst
机构: Peter MacCallum Cancer Centre
每年引用次数
引用次数
引用: 16,440
H-指数: 64
I10-指数 : 124
出版物: 287
Tumor Localization of 16β-18F-Fluoro-5α-Dihydrotestosterone Versus 18F-FDG in Patients with Progressive, Metastatic Prostate Cancer
Olivia Squire , Yusuf Erdi , Howard Scher , Michael Welch
The Journal of Nuclear Medicine 45 ( 3) 366 -373
392
2004
64Cu-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry for Peptide Receptor Radionuclide Therapy.
Rodney J. Hicks , Price Jackson , Grace Kong , Robert E. Ware
The Journal of Nuclear Medicine 60 ( 6) 777 -785
34
2019
Incidental cardiac findings on routine oncology FDG-PET/CT scans: Normal variants, benign and pathologic conditions with histopathologic correlation
Clare Smith , Michael Baum , Tim Akhurst
The Journal of Nuclear Medicine 48
2007
Abnormal Colonic Accumulation of Fluorine-18-FDG in Pseudomembranous Colitis
Salvatore Berlangieri , Anthony Hannah , Andrew M. Scott , James Bishop
The Journal of Nuclear Medicine 37 ( 10) 1683 -1685
49
1996
Combined 18F-FDG and 11C-Methionine PET Scans in Patients with Newly Progressive Metastatic Prostate Cancer
Iman Osman , Homer A Macapinlac , Tim Akhurst , Henry W D Yeung
The Journal of Nuclear Medicine 43 ( 1) 46 -55
140
2002
Hybrid PET/CT machines: optimized PET machines for the new millennium?
Roland Chisin , Tim Akhurst
The Journal of Nuclear Medicine 41 ( 5) 961 -961
14
2000
Phase I Safety and Biodistribution Study of 124I-PEG-AVP0458 Diabody in Patients with TAG-72 Positive Ovarian and Prostate Cancer
Marika Ciprotti , Andrew Weickhardt , Ian Davis , Peter Hudson
The Journal of Nuclear Medicine 56 280 -280
2015
PET-based whole body dosimetry of 18F-FACBC, a tumor-avid non-metabolized amino acid: Initial results in patients
Ronald Blasberg , Eva Burnazi , Tim Akhurst , Nagavakishore Pillarsetty
Society of Nuclear Medicine Annual Meeting Abstracts 47
3
2006
High activity, pain reduction and low toxicity with Lutetium-177 PSMA617 theranostics in metastatic castrate-resistant prostate cancer (mCRPC): results of a phase II prospective trial
John Violet , Michael Hofman , Scott Williams , Shahneen Sandhu
The Journal of Nuclear Medicine 59 531 -531
4
2018
Lung Cancer Preface
Tim Akhurst , Gang Cheng
Pet Clinics 13 ( 1)
2018
Molecular imaging of neuroendocrine differentiation of prostate cancer: a case series
Michael S. Hofman , Shahneen Sandhu , Rodney J. Hicks , Amir Iravani
Clinical Genitourinary Cancer
1
2021
FDG PET in the evaluation of immune-related hypophysitis and thyroiditis following combination ipilimumab and nivolumab in advanced melanoma
Arian Lasocki , Nirupa Sachithanandan , Shahneen Sandhu , Rodney Hicks
The Journal of Nuclear Medicine 61 482 -482
2020
The role of 18 F-FDG-PET/CT in evaluating retroperitoneal masses -Keeping your eye on the ball!
Te-Jui Hung , Luke McLean , Catherine Mitchell , Claire Pascoe
Cancer Imaging 19 ( 1) 28
3
2019
An increasingly common challenge: management of the complete responder with multi-focal metastatic colorectal cancer.
Deborah Schrag , Martin Weiser , Mark Schattner , Jinru Shia
Journal of Clinical Oncology 23 ( 9) 1799 -1802
16
2005
A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients.
Harvey G Moore , Tim Akhurst , Steven M Larson , Bruce D Minsky
Journal of The American College of Surgeons 197 ( 1) 22 -28
76
2003
Radioiododeoxyuridine (125I-IUDR) is effective therapy for liver cancer and tolerable after hepatectomy
Jonathan Zager , Keith Delman , Sandeep Malhotra , Michael Ebright
Journal of The American College of Surgeons 191 ( 4)
2000
The Victorian Comprehensive Cancer Centre lung cancer clinical audit: collecting the UK National Lung Cancer Audit data from hospitals in Australia
Linda Mileshkin , Catherine Dunn , Hannah Cross , Mary Duffy
Internal Medicine Journal 49 ( 8) 1001 -1006
2019
[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study.
Michael S Hofman , John Violet , Rodney J Hicks , Justin Ferdinandus
Lancet Oncology 19 ( 6) 825 -833
776
2018
O-31 18FDG-PET SUV: Prognostic value for surgically treated lung cancer
Robert J. Downey , Tim Akhurst , Mithat Gonen , Alain Vincent
Lung Cancer 41 S13
2003
O-185 CT and FDG PET characteristics of bronchoalveolar carcinoma
Robert T. Heelan , Tim Akhurst , Maureen F. Zakowski , Valerie Rusch
Lung Cancer 41
2003